Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 17-acetoxy-6-chloro-2-oxa-4,6 Pregnadiene-3,20-dione
2. 2-oxachloromadinone Acetate
3. Tzp 4238
4. Tzp-4238
1. Osaterone Acetate Ester
2. 105149-00-6
3. Tzp-4238
4. Fr26fsv5ez
5. 2-oxapregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-chloro-
6. Osaterone Acetate (jan)
7. Osaterone Acetate [jan]
8. Ypozane
9. Tzp 4238
10. Ccris 6738
11. Unii-fr26fsv5ez
12. Hipros
13. 17-(acetyloxy)-6-chloro-2-oxapregna-4,6-diene-3,20-dione
14. 17-alpha-acetoxy-6-chloro-2-oxa-4,6-pregnadiene-3,20-dione
15. [(1r,3as,3br,9ar,9bs,11as)-1-acetyl-5-chloro-9a,11a-dimethyl-7-oxo-2,3,3a,3b,9,9b,10,11-octahydroindeno[4,5-h]isochromen-1-yl] Acetate
16. 7-acetyl-7-(acetyloxy)-11-chloro-4ar,4b,5,6,6as,7r,8,9,9as,9br-decahydro-4a,6a-dimethylcyclopenta(5,6)naphtho(1,2-c)pyran-2(4h)-one
17. Schembl528987
18. Chebi:81713
19. 2-oxochlormadinone Acetate
20. Dtxsid501030455
21. Osaterone Acetate Ester [mi]
22. Cyclopenta(5,6)naphtho(1,2-c)pyran-2(4h)-one, 7-acetyl-7-(acetyloxy)-11-chloro-4a,4b,5,6,6a,7,8,9,9a,9b-decahydro-4a,6a-dimethyl-, (4ar,4bs,6as,7r,9as,9br)-
23. C18375
24. D11105
25. Osaterone Acetate [ema Epar Veterinary]
26. Q27155575
27. 17alpha-acetoxy-6-chloro-2-oxapregna-4,6-diene-3,20-dione
| Molecular Weight | 406.9 g/mol |
|---|---|
| Molecular Formula | C22H27ClO5 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 406.1547017 g/mol |
| Monoisotopic Mass | 406.1547017 g/mol |
| Topological Polar Surface Area | 69.7 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 829 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of benign prostatic hypertrophy (BPH) in male dogs.
Androgen Antagonists
Compounds which inhibit or antagonize the biosynthesis or actions of androgens. (See all compounds classified as Androgen Antagonists.)
QG04CX90
ABOUT THIS PAGE
A Osaterone acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Osaterone acetate, including repackagers and relabelers. The FDA regulates Osaterone acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Osaterone acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Osaterone acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Osaterone acetate supplier is an individual or a company that provides Osaterone acetate active pharmaceutical ingredient (API) or Osaterone acetate finished formulations upon request. The Osaterone acetate suppliers may include Osaterone acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Osaterone acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Osaterone acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Osaterone acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Osaterone acetate GMP manufacturer or Osaterone acetate GMP API supplier for your needs.
A Osaterone acetate CoA (Certificate of Analysis) is a formal document that attests to Osaterone acetate's compliance with Osaterone acetate specifications and serves as a tool for batch-level quality control.
Osaterone acetate CoA mostly includes findings from lab analyses of a specific batch. For each Osaterone acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Osaterone acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Osaterone acetate EP), Osaterone acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Osaterone acetate USP).
LOOKING FOR A SUPPLIER?
